期刊文献+

多巴胺能神经元对鱼藤酮敏感性的增龄改变及其机制 被引量:1

Aging-related sensibility of dopaminergic neurons to rotenone
原文传递
导出
摘要 目的研究鱼藤酮对不同月龄SD大鼠多巴胺能神经元的影响及其机制。方法3、12、20月龄雄性SD大鼠各40只,按照随机数字表法分为自然增龄组和鱼藤酮处理组,每组20只。自然增龄组皮下注射无鱼藤酮的混合溶剂,处理组皮下注射鱼藤酮[1.0mg/(kg·d)],连续给药30d,每周停药1d,构建大鼠鱼藤酮染毒模型。大鼠黑质切片采用酪氨酸羟化酶(TH)免疫组化染色;测定黑质组织匀浆超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性;Western blotting检测黑质部位caspase-3表达水平。结果鱼藤酮处理后各月龄大鼠TH阳性细胞计数均比相应自然增龄组降低,且20月龄大鼠降低最为明显,差异均有统计学意义(P〈0.05)。自然增龄组3月龄大鼠黑质组织SOD和CAT活性最高,20月龄大鼠有所下降,而鱼藤酮处理后各月龄大鼠SOD、CAT活性均明显增加,差异有统计学意义(P〈0.05)。Western blotting结果显示,鱼藤酮处理组各月龄大鼠剪切活化的caspase-3的表达较自然增龄组均明显增加,差异有统计学意义(P〈0.05),其中20月龄大鼠最为明显。结论鱼藤酮可诱导大鼠TH阳性细胞随年龄增加而减少,氧化应激水平的增高和caspase-3的激活可能参与了SD大鼠对鱼藤酮敏感性随年龄增加的作用机制。 Objective To investigate the influence of rotenone neurotoxin on dopaminergic neurons from SD rats of different months and its mechanism. Methods Forty 3-month-old, 40 12-month-old and 40 20-month-old SD rats were chosen in our study and equally randomized into control group and rotenone treatment group, respectively (n=20); rotenone (1.0 mg/[kg· d]) was given to the rats in the rotenone treatment group for 30 consecutive d (having drug withdrawal 1 d per week) to induce rotenone neurotoxin models. Tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta (SNpc) was observed. Levels of total superoxide dismutase (SOD) and catalase (CAT) were determined by colorimetric method and protein level of caspase-3 was determined by Western blotting. Results A significant decreased number of TH-positive cells in 3-, 12- and 20-month-old rats of rotenone treatment group was noted as compared with that in the control group, respectively (P〈0.05), and 20-month-old rats had the fewest number. SOD and CAT activities in 3 month-old rats of the control group enjoyed the highest level and decreased trend was noted in 20 month-old rats of the control group; as compared with those in the control group, the SOD and CAT activities in all the rats of rotenone treatment group increased significantly (P〈0.05). Western blotting revealed that the expression of cleaved caspase-3 in all the rats of rotenone treatment group obviously increased as compared with those in the control group, and 20-month-old rats showed the highest level of active caspase-3. Conclusion Rotenone can induce the decrease of TH-positive cell level following the increase of rat age; increase levels of caspase-3 and oxidative stress may take part in the mechanism of high sensibility of old SD rats to rotenone.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第11期1101-1105,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金重点项目(30930035) 省属高校自然科学研究项目(10KJB320016)
关键词 帕金森病 老化 鱼藤酮 氧化应激 半胱氨酸蛋白酶-3 Parkinson' s disease Aging Rotenone Oxidative stress Caspase-3
  • 相关文献

参考文献17

  • 1Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai [J]. Lancet, 2005, 365 (9459): 595-597.
  • 2张世忠.帕金森病治疗进展[J].中华神经医学杂志,2007,6(12):1189-1191. 被引量:6
  • 3Thomas B, Beal MF. Mitochondrial therapies for Parkinson's disease[J]. Mov Disord, 2010, 25 Suppl 1: S155-160.
  • 4Liu CY, Lee CF, Wei YH. Role of reactive oxygen species-elicited apoptosis in the pathophysiology of mitochondrial and neurodegenerative diseases associated with mitochondrial DNA mutations[J]. J Formos Med Assoc, 2009, 108(8): 599-611.
  • 5赵喜林,顾振纶,秦正红.长期低剂量皮下注射鱼藤酮制作大鼠帕金森病模型[J].中国药理学通报,2005,21(10):1274-1277. 被引量:27
  • 6Hindle JV. Ageing, neurodegeneration and Parkinson's disease [J]. Age Ageing, 2010, 39(2): 156-161.
  • 7Schmidt WJ, Alam M. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD)[J]. J Neural Yransm Suppl, 2006, (70): 273-276.
  • 8Paradies G, Petrosillo G, Paradies V, et al. Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin [J]. Neurochem Int, 2011, 58(4): 447-457.
  • 9Phinney AL, Andringa G, Bol JG, et al. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging [J]. Parkinsonism Relat Disord, 2006, 12(4): 228-238.
  • 10Bazzu G, Calia G, Puggioni G, et al. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach [J]. CNS Neurol Disord Drag Targets, 2010, 9 (4): 482-490.

二级参考文献35

共引文献33

同被引文献12

  • 1Olanow CW, Stem MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009)[J]. Neurology, 2009, 72(21 Suppl 4): S1-S136.
  • 2Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. Missing pieces in the Parkinson's disease puzzle[J]. Nat Med, 2010, 16(6): 653-661.
  • 3ViUar-Cheda B, Dominguez-Meijide A, Joglar B, et al. Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors[J]. Neurobiol Dis, 2012, 47(2): 268-279.
  • 4Mertens B, Varcin M, Michotte Y, et al. The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death [J]. Eur J Neurosci, 2011, 34(7): 1141-1148.
  • 5Wright JW, Harding JW. Importance of the brain Angiotensin system in Parkinson's disease[J]. Parkinsons Dis, 2012: 860923.
  • 6Fu H, Hosomi N, Pelisch N, et al. Therapeutic effects ofpostischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia [J]. J Hypertens, 2011, 29(11): 2210-2219.
  • 7Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, et al. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease[J]. J Neurochem, 2009, 109(2): 656-669.
  • 8Cannon JR, Tapias V, Na HM, et al. A highly reproducible rotenone model of Parkinson's disease [J]. Neurobiol Dis, 2009, 34 (2): 279-290.
  • 9Colla E, Jensen PH, Pletnikova O, et al. Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo [J]. J Neurosci, 2012, 32 (10): 3301-3305.
  • 10Kalia LV, Kalia SK, Mclean PJ, et al. alpha-Synuclein oligomers and clinical implications for Parkinson disease [J]. Ann Neurol, 2013, 73(2): 155-169.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部